Industrial Machinery & Robotics Global On demand · 24-48h

Global Pipette Robots Market Strategic Research Report

Global Pipette Robots Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pipette Robots Market
$1.15B2025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Semi-automatic, Fully automatic

By Application: Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Flow Robotic, BRANDTECH Scientific, Integra Biosciences, Waters Corporation, HighRes Biosolutions, Bio Molecular Systems (BMS), Endress+Hauser, Zinsser, Opentrons, Beckman Coulter, Eppendorf, Hamilton, Qinstruments(BICO), Gilson, Formulatrix, Aurora Biomed, Tecan Group, Agilent Technologies, Hudson Robotics, Mettler Toledo, Shanghai Benyou Technology, Shenzhen MGI Tech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 150 pages
Market size 2025
$1.15B
Billion USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$1.8B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Pipette Robots market size is predicted to grow from US$ 1,146 million in 2025 to US$ 1,805 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

In 2025, global Pipette Robots production reached approximately 11.6 k units with an average global market price of around k US$105 per unit. Single-line annual production capacity averages 600 units with a gross margin of approximately 28-30%. The upstream of Pipette Robots primarily includes core components such as precision machinery, sensors, and control systems, which are predominantly concentrated in the fields of biotechnology and automation equipment manufacturing; the downstream applications are extensive, with biopharmaceutical companies accounting for approximately 40%, government institutions and medical institutions each accounting for about 20%, universities and research institutions accounting for about 15%, and other fields such as chemistry and food testing accounting for about 25%. The demand for Pipette Robots is on the rise with the growing need for laboratory automation, and with the rapid development of new drug research and personalized medicine, the industry is poised to see new growth points, particularly in the areas of precision medicine and bio-safety detection.

Pipette Robots are sophisticated mechanical systems designed to automate the precise transfer of liquids with exceptional accuracy and efficiency. These robots are equipped with advanced pipetting mechanisms that can handle a wide range of volumes and types of liquids, ensuring minimal variability and reduced human error. The core of these systems lies in their ability to replicate human pipetting techniques, but with the added advantage of precision and consistency, which is unattainable through manual pipetting. Their benefit lies in their unparalleled speed, reliability, and adaptability, enabling them to perform complex pipetting tasks with minimal downtime and maximum throughput. These robots are essentially the backbone of laboratory automation, providing the foundation for a wide array of applications that require precise liquid handling.

The future development trends of the Pipette Robots industry will focus on enhancing experimental precision and sensitivity, achieving multifunctionality and adaptability, integrating intelligent and automated technologies, supporting remote control and operation, and providing integrated solutions. Simultaneously, with the maturation of technology and the scaling up of production, cost-effectiveness will be improved, making these robots more accessible. Furthermore, the robots will strengthen bio-safety protection, be closely integrated with data analysis software, offer personalized customization services, and adapt to various laboratory environments, including working under extreme conditions. These comprehensive developments will drive Pipette Robots to play an even more critical role in fields such as precision medicine, personalized healthcare, and new drug research.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pipette Robots market?

What factors are driving Pipette Robots market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pipette Robots market opportunities vary by end market size?

How does Pipette Robots break out by Type, by Application?

This report presents a comprehensive overview of the global Pipette Robots market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Semi-automatic
  • Fully automatic

Segment by Form

  • Benchtop Type
  • Floor-standing Type

Segment by Channel Number

  • Single Channel
  • Multi-channel

Segment by Application

  • Biopharmaceutical Company
  • Government Agency
  • Medical Institution
  • University and Research Institute
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pipette Robots market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biopharmaceutical Company, Government Agency, Medical Institution evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pipette Robots Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.15B
2025
Forecast
$1.8B
2032
CAGR
6.7%
2025–2032
Régions
5
global
Key companies
Flow RoboticBRANDTECH ScientificIntegra BiosciencesWaters CorporationHighRes BiosolutionsBio Molecular Systems (BMS)Endress+HauserZinsser
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Semi-automaticFully automatic
By Application
Biopharmaceutical CompanyGovernment AgencyMedical InstitutionUniversity and Research InstituteOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Semi-automatic
  • 3.1.3 Fully automatic
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biopharmaceutical Company
  • 4.1.3 Government Agency
  • 4.1.4 Medical Institution
  • 4.1.5 University and Research Institute
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Flow Robotic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BRANDTECH Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Integra Biosciences
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Waters Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 HighRes Biosolutions
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bio Molecular Systems (BMS)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Endress+Hauser
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Zinsser
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Opentrons
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Beckman Coulter
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Eppendorf
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hamilton
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Qinstruments(BICO)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Gilson
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Formulatrix
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Aurora Biomed
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Tecan Group
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Agilent Technologies
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Hudson Robotics
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Mettler Toledo
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shanghai Benyou Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Shenzhen MGI Tech
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Pipette Robots market?
The global Pipette Robots market is estimated at US$ 1.15 billion in 2025 (base year) and is projected to reach US$ 1.8 billion by 2032.
How fast is the Pipette Robots market expected to grow?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 1.15 billion in 2025 to US$ 1.8 billion in 2032, roughly 1.6 times its base-year value.
What does the Pipette Robots market cover?
In 2025, global Pipette Robots production reached approximately 11.6 k units with an average global market price of around k US$105 per unit. Single-line annual production capacity averages 600 units with a gross margin of approximately 28-30%.
How is the Pipette Robots market segmented by type?
By type, the market is segmented into Semi-automatic and Fully automatic.
What are the key applications of Pipette Robots?
Key applications covered include Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute and Others.
Which companies are profiled in the Pipette Robots market report?
Key players profiled include Flow Robotic, BRANDTECH Scientific, Integra Biosciences, Waters Corporation, HighRes Biosolutions, Bio Molecular Systems (BMS), Endress+Hauser and Zinsser, among 22 companies covered in total.
What geographies does the Pipette Robots market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Pipette Robots?
What factors are driving Pipette Robots market growth, globally and by region?
Who should buy the Pipette Robots market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biopharmaceutical Company, Government Agency and Medical Institution, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pipette Robots market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.